What is included?

• Trucheck Intelli Whole-body blood test
• Whole-body MRI Scan
• Hereditary Cancer Test

Our Comprehensive Cancer Screening Package combines our three most comprehensive services to deliver an in-depth assessment of both your current health and future risk. This package includes the Trucheck Intelli whole-body blood test, a Whole-body MRI Scan, and our Hereditary Cancer Panel which includes 31 different genes and has been expertly curated using current literature and national testing guidelines to maximise clinical actionability, whilst minimising uncertainty. This multi-cancer panel targets genes associated with breast, ovarian, colorectal, prostate, melanoma, and pancreatic cancer.

Together, these advanced tests provide a powerful overview of your health. The Trucheck Intelli test detects circulating tumour cells that may indicate the presence of cancer at an early stage, while the Whole-body MRI Scan offers detailed, radiation-free imaging to identify structural abnormalities throughout the body. In addition, the hereditary cancer panel analyses your DNA to reveal genetic variants that may increase your predisposition to certain cancers.

This combination makes the Comprehensive Package an ideal way to begin your cancer screening journey—delivering clarity, reassurance, and actionable insights for proactive healthcare planning.

For Whom?

This package is most suitable for asymptomatic individuals over the age of 40, who are looking for a view of both their current health and future risk.

What
A prescription blood test that can help detect cancers based on the presence of Circulating Tumour Cells (CTC’s). The test has a 88.2% sensitivity in detection of cancers across all stages and types. Furthermore, it has a 93.1% accuracy in determining the tissue or organ of origin in positive cases. Thus, even early stage cancers are reliably detected. Furthermore, Trucheck specificity is 96.3% in asymptomatic individuals and 95% in individuals with benign tumours.

For Whom
Asymptomatic adult males and females with no previous cancer diagnosis and above the age of 35 years old.

How
Blood samples are evaluated the presence of circulating tumour cells (CTC’s) which may be further analysed to determine the organ or tissue of origin. The blood test appointment takes 20-30 minutes and you will receive your results within 2 weeks.

Why
The Trucheck Intelli blood test is a convenient, accurate and safe way to detect cancer at the earliest stage.

What 

Hereditary cancer is defined as cancer caused by an inherited genetic variant in a cancer susceptibility gene. Identifying a genetic fault means you have an increased risk of developing cancer, but it doesn’t mean that you have or will be diagnosed with cancer in the future.

What

Our mole mapping machine allows a full 360 degree view of your skin. This will document all your moles in great detail and the images will be stored for mole monitoring purposes. The fully integrated software allows us to map and monitor pigmented lesions and distributed diseases of the skin. Individual moles can also be examined in greater detail using a microscopic light called a dermatoscope. All the images are examined by a dermatology consultant and stored securely. The mole mapping machine then uses artificial intelligence to flag up any changes to moles when mapping is repeated at a later date. Mole mapping will also identify any new moles that have appeared since the previous mapping images were taken.

Why

You may have a large number of moles, moles that are changing in shape and size, or moles that look a bit odd. You may have had abnormal moles removed in the past, or a family history of problems with moles or skin cancer. You may have lived in sunny countries in the past, and have skin that is sensitive to the sun. You may work outside, or enjoy regular outdoor recreational activities leaving you vulnerable to sun damage on your skin. You may recall lots of sunburn in the past. Or you could simply want peace of mind that your whole skin will be checked and all your moles mapped and evaluated.

How

Typically you will see the dermatology consultant first and they will take a skin cancer/sun damage history (skin type, living in sunny countries, previous abnormal moles, family history of skin cancer, medications you may be taking, degree of UV exposure associated with work/leisure) to assess your risk. They will then examine your skin in the clinic room and identify any moles that require dermatoscopy images to be taken at the time of the mole mapping.

You will then move to the mole mapping room and be asked to undress down to your underwear (underpants only) and then images of your skin will be taken (standing up in the machine). An entire 360 map of your entire skin is taken in a few seconds by the multiple cameras, generating a 3D avatar of your entire body and skin surface. Please note that there is no associated radiation exposure with taking the images. You then get dressed and will be given a USB with your images saved, as well as a topline report of findings.

You will receive a full consultant report within two weeks via email, which will also contain advice on when you should next come in for mole mapping, and whether you need any follow-up treatment.

Faecal Immunochemical Testing (FIT)

What

The FIT test analyses stool samples to identify possible signs of bowel cancer, such as blood in the stool that you might not be able to see. It has a sensitivity of 88% and a specificity of 91% for colorectal cancer.

Patients with a positive FIT result can be referred for further investigation. The earlier bowel cancer is found, the more effective treatments will be and the more curable the cancer. 

For whom

The FIT test is available for both males and females over 18 years of age.

How

• Gently scrape the outer surfaces of the stool, until the grooved end of the probe is evenly covered.
• Insert the probe into the tube and twist until you hear it click shut.
• Secure the sample into the sample tube mailer and place into original shipping box.
• Place the box into the prepaid envelope and seal.
• Post via Royal Mail Postal box.
• It takes approximately 5 working days for analysis once the sample has been received at the laboratory.

Why

Bowel cancer is the fourth most common cancer in the UK and the second biggest cancer killer. Nearly 43,000 individuals are diagnosed with bowel cancer every year in the UK (Bowel Cancer UK, July 2023). The FIT test is currently used as a bowel cancer screening method for over 50’s by the NHS, however, more than 2600 people under 50 are diagnosed each year in the UK (Bowel Cancer UK, Autumn 2022). These individuals will be missed by the screening programme, therefore diagnosis won’t occur until they develop symptoms and go through the NHS diagnostic pathway. This test reaches those people to ensure that if bowel cancer is present, it is diagnosed at the earliest possible stage when treatment is most successful.  

The blood test and Whole-Body MRI scan are two separate parts of the programme and can be chosen independently.

Why

Depending on the risk assessment of your medical history, family history, and blood test results, we may advise you to have the MRI scan.

What

MRI stands for Magnetic Resonance Imaging. An MRI machine is a large magnet which uses strong magnetic fields to ‘see inside’ your body. It is completely pain-free and requires no injections. The scan extends from the top of your head to the middle of your thighs and takes approximately 1 hour to perform. You will be able to listen to music with special headphones for the duration of the scan. 

A full safety questionnaire will be undertaken prior to your attendance at the scan clinic to exclude any possible contra-indications for the session.

Is the process safe?

Yes. MRI scans have been used since the 1980s and are proven safe. Unlike other medical imaging procedures such as CT (CAT scan) and X-ray, MRIs do not expose you to harmful radiation.

• To triage symptomatic individuals who have been advised an invasive tissue biopsy to check for malignancy
• Patients where an invasive biopsy has been inconclusive or inconsistent with clinical observations
• Suspected metastatic relapse to rule out a new primary cancer.
• Every Individual who desires a “risk free biopsy”

What
Non-invasive diagnostic biopsy to substitute invasive tissue extraction.

Why
Invasive biopsies are risky, inconvenient, painful, and must be performed in a clinical setting. Trublood sample is a simple 25ml blood draw that can be collected from a patient’s house or office.

How
Circulating tumour cells are isolated from a patient’s blood sample and extensively analysed for diagnosis, prognosis, and theranostics.